Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03408717 · ClinicalTrials.gov registry record

Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery

A clinical trial of Breast Cancer and Chronic Pain, sponsored by KK Women's and Children's Hospital.

Active
Registry status
220
Enrollment target
2
Study locations

NCT03408717: Active study of Breast Cancer and Chronic Pain, sponsored by KK Women's and Children's Hospital.

NCT03408717 is a study of Breast Cancer and Chronic Pain that is active but no longer recruiting, run by KK Women's and Children's Hospital. The registered enrollment target is 220 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03408717, a study of Breast Cancer and Chronic Pain, is active but no longer recruiting, sponsored by KK Women's and Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
220 participants
Enrollment target
2
Study locations

Study Summary

Pre-existing pain and severe postoperative pain are predictors of persistent pain after surgery, but a complete understanding on the development of persistent pain is still lacking. The study aims to identify clinically relevant and genetic risk factors for persistent postsurgical pain that can be reliably distinguished statistically.

Primary Outcome

Persistent pain is defined as having one of the below criteria at 4 months after surgery: i) having pain score at rest (Numeric Rating Scale 0 to 100) of 30 or more; or ii) having pain score on movement (Numeric Rating Scale 0 to 100) of 30 or more; or iii) or "yes" to one of the seven questions on the presence of pain in daily life activities (mood, walking, carrying heavy loads, work, relations with people, sleep, enjoyment of life)

Interventions

  • OTHER Questionnaires
  • OTHER Mechanical Temporal Summation assessment
  • OTHER Pain threshold assessment

Study Locations (2)

North Carolina

  • Duke University Medical Center - Durham

Other

  • KK Women's and Children's Hospital - Singapore

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2018-01-03
Est. Completion 2026-12-31

What the registry record for NCT03408717 still lists

NCT03408717 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower).

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Questionnaires is the first listed.

NCT03408717 reports a single indexed study location in North Carolina, Other.

Frequently Asked Questions

What is clinical trial NCT03408717 about?

NCT03408717 is a clinical study titled "Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery". Pre-existing pain and severe postoperative pain are predictors of persistent pain after surgery, but a complete understanding on the development of persistent pain is still lacking. The study aims to identify clinically relevant and genetic risk factors for persistent postsurgical pain that can be r...

What is the current status of trial NCT03408717?

This trial is currently active not recruiting. The enrollment target is 220 participants. The study started on 2018-01-03. Estimated completion is 2026-12-31.

What conditions does trial NCT03408717 study?

This clinical trial studies the following conditions: Breast Cancer, Chronic Pain, Acute Pain, Depression, Anxiety.

What interventions are being tested in trial NCT03408717?

The interventions under investigation include: Questionnaires (OTHER), Mechanical Temporal Summation assessment (OTHER), Pain threshold assessment (OTHER).

Who is sponsoring clinical trial NCT03408717?

This trial is sponsored by KK Women's and Children's Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03408717 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03408717's enrollment target sits among peer trials

220 342nd of 1224 higher than 881 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03408717, the US trial registry maintained by the National Library of Medicine. NCT03408717 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.